Oral recombinant Helicobacter pylori vaccine Phase III clinical trial completed

reporter 11 from the Third Military Medical University was informed that the national class I new drug - oral recombinant Helicobacter pylori vaccine (referred to as gastric disease vaccine) Phase III clinical trial has been completed in Chongqing, is expected to be officially put into production in the near futureIt is reported that this vaccine by the Third Military Medical University, the department of testing professor Yan Quanming rate of scientific research team lasted more than ten years to complete, is the world's first to complete the Phase III clinical trial of the Helicobacter pylori gastric disease vaccine, but also the true sense of the Chinese independent research and development, with full independent intellectual property rights of the original vaccineAccording to the observation results of phase III clinical trials of more than 5000 people, the vaccine's protection rate of prevention of Helicobacter pylori infection is greater than 72.1%, and has good preventive effect for gastroenteritis, stomach ulcers and duodenal ulcers, such as upper-leveldiseasesNo clinically adverse symptoms were observed, indicating that the vaccine had good safety and efficacy on humansAt present, the vaccine has been awarded two national invention patentsIt is reported that the Beiji District Government has granted 500 acres of industrial park land, dedicated to the "gastric disease vaccine" industrialization base constructionHelicobacter pylori is theof the digestive tractdisease
Helicobacter pylori (Hp), the bacteria that settle in the human stomach, is the cause of chronic gastritis, stomach ulcers and duodenal ulcers and other upper digestive diseasesIn 1994, who confirmed that it was closely related to the occurrence of stomach cancer and classified it as a category I carcinogenAt present, about 50% of the world's population is affected by Hp infection and related diseases, china infected more than 600 million people, about 200,000 people die of stomach cancer each year(Zhao Junhui Xiong Xueli Huang Han)